Thyroid function and thyroid autoimmunity in type 1 diabetes mellitus: impact on glycemic control
DOI:
https://doi.org/10.18203/2349-3291.ijcp20232486Keywords:
T1DM, Autoimmune thyroid disease, Anti TPO antibodies, Glycemic controlAbstract
Background: The frequency of AITD (autoimmune thyroid disease) and prevalence of thyroid autoantibodies in T1DM (Type 1 diabetes mellitus) patients is much higher than in general paediatric population, varying widely between 3-50% and is often related to age, gender and ethnicity. Although this association has been well established in various populations, very few studies have been done in this regard in South India. The objectives of the study were to study the proportion of abnormal thyroid function and thyroid autoimmunity among T1DM subjects in comparison with general pediatric population and to compare the disease severity among T1DM subjects with and without abnormal thyroid function.
Methods: The 45 subjects diagnosed with T1DM (Group 1) and 45 age and gender matched subjects without T1DM (Group 2) were enrolled after applying the inclusion and exclusion criteria. Serum free T3, free T4 and TSH levels were tested for all the subjects in both the groups. In addition, HbA1c levels and Anti TPO antibody titers were tested for subjects with T1DM.
Results: Abnormal thyroid function was found in 15.5% of T1DM subjects, in contrast to 2.2% of subjects in the comparison group (p=0.026). The anti-TPO antibody titers were positive in 31.1% of T1DM subjects and among them 42.8% subjects had abnormal thyroid function. T1DM subjects with abnormal thyroid function had significantly higher number of hospitalizations (p<0.05) and total number of ICU admissions (p<0.05)
Conclusions: Abnormal thyroid function (predominantly subclinical hypothyroidism) and thyroid autoimmunity was not only more prevalent among T1DM subjects, but was also associated with poor glycemic control. Thus, highlighting the need for screening and a lower threshold for treatment.
Metrics
References
Fröhlich-Reiterer E, Elbarbary NS, Simmons K, Buckingham B, Humayun KN, Johannsen J, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2022;23(8):1451-67.
Hughes JW, Riddlesworth TD, DiMeglio LA, Miller KM, Rickels MR, McGill JB; T1D Exchange Clinic Network. Autoimmune Diseases in Children and Adults with Type 1 Diabetes From the T1D Exchange Clinic Registry. J Clin Endocrinol Metab. 2016;101(12):4931-7.
Brenta G. Diabetes and thyroid disorders. Br J Diabetes Vasc Dis. 2010;10:1727.
Kordonouri O, Hartmann R, Deiss D, Wilms M, Grüters-Kieslich A. Natural course of autoimmune thyroiditis in type 1 diabetes: association with gender, age, diabetes duration, and puberty. Arch Dis Child. 2005;90(4):411-4.
Biondi B, Kahaly GJ, Robertson RP. Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders. Endocr Rev. 2019;40(3):789-824.
Duntas LH, Orgiazzi J, Brabant G. The interface between thyroid and diabetes mellitus. Clin Endocrinol (Oxf). 2011;75(1):1-9
Libman I, Haynes A, Lyons S, Pradeep P, Rwagasor E, Tung JY et al. ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2022;23(8):1160-74.
Khadilkar V, Yadav S, Agrawal KK, Tamboli S, Banerjee M, Cherian A et al. Revised IAP growth charts for height, weight and body mass index for 5-to 18-year-old Indian children. Indian Pediatr. 2015;52:47-55.
Kliegman RM, Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM et al. Nelson textbook of paediatrics. 21 ed. Philadelphia: Elsivier. 2020.
Sanyal D, Majumder A, Chaudhuri S, Chatterjee S. Thyroid profile and autoantibodies in Type 1 diabetes subjects: A perspective from Eastern India. Indian J Endocrinol Metabol. 2017;21(1):45.
Umpierrez GE, Latif KA, Murphy MB, Lambeth HC, Stentz F, Bush A, Kitabchi AE. Thyroid dysfunction in patients with type 1 diabetes. Longitudinal study Diabetes Care. 2003;26(4):1181-5.
Radaideh A, El-Khateeb M, Batieha AM, Nasser AS, Ajlouni KM. Thyroid function and thyroid autoimmunity in patients with type 1 diabetes mellitus. Saudi Med J. 2003;24(4):352-5.
Metwalley KA, El-Saied AA. Thyroid abnormalities in Egyptian children and adolescents with type 1 diabetes mellitus: A single center study from Upper Egypt. Indian J Endocr Metab 2014;18:637-41.
Al-Khawari M, Shaltout A, Qabazard M, Al-Sane H, Elkum N. Prevalence of Thyroid Autoantibodies in Children, Adolescents and Young Adults with Type 1 Diabetes in Kuwait. Med Principles Pract. 2015;24(3):280-84.
Menon PS, Vaidyanathan B, Kaur M. Autoimmune thyroid disease in Indian children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2001;14(3):279-86.
Mantovani RM, Mantovani LM, Dias VM. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus: prevalence and risk factors. J Pediatr Endocrinol Metab. 2007;20(6):669-75.
Kordonouri O, Klinghammer A, Lang EB, Grüters-Kieslich A, Grabert M, Holl RW. Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. Diabetes Care. 2002;25(8):1346-50.
Kakleas K, Paschali E, Kefalas N, Fotinou A, Kanariou M, Karayianni C et al. Factors for thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Upsala J Med Sci. 2009;114(4):214-20.
Chase HP, Garg SK, Cockerham RS, Wilcox WD, Walravens PA. Thyroid hormone replacement and growth of children with subclinical hypothyroidism and diabetes. Diabet Med. 1990;7(4):299-303.